CN Patent

CN110577524B — 一种激酶选择性抑制剂

Assigned to Peking University Shenzhen Graduate School · Expires 2022-01-28 · 4y expired

What this patent protects

本发明涉及一种激酶选择性抑制剂，包含其的药物组合物，以及其的医药用途。

USPTO Abstract

本发明涉及一种激酶选择性抑制剂，包含其的药物组合物，以及其的医药用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110577524B
Jurisdiction
CN
Classification
—
Expires
2022-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Peking University Shenzhen Graduate School
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.